VOOZH about

URL: https://pubmed.ncbi.nlm.nih.gov/32491919/

⇱ Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review - PubMed


Clipboard, Search History, and several other advanced features are temporarily unavailable.
Skip to main page content
πŸ‘ Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

πŸ‘ Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly throughout the world since the first cases of coronavirus disease 2019 (COVID-19) were observed in December 2019 in Wuhan, China. It has been suspected that infected persons who remain asymptomatic play a significant role in the ongoing pandemic, but their relative number and effect have been uncertain. The authors sought to review and synthesize the available evidence on asymptomatic SARS-CoV-2 infection. Asymptomatic persons seem to account for approximately 40% to 45% of SARS-CoV-2 infections, and they can transmit the virus to others for an extended period, perhaps longer than 14 days. Asymptomatic infection may be associated with subclinical lung abnormalities, as detected by computed tomography. Because of the high risk for silent spread by asymptomatic persons, it is imperative that testing programs include those without symptoms. To supplement conventional diagnostic testing, which is constrained by capacity, cost, and its one-off nature, innovative tactics for public health surveillance, such as crowdsourcing digital wearable data and monitoring sewage sludge, might be helpful.

PubMed Disclaimer

Comment in

References

    1. COVID-19 Case Tracker. Johns Hopkins Coronavirus Resource Center. 2020. Accessed at https://coronavirus.jhu.edu. on 26 May 2020.
    1. Nishiura H, Kobayashi T, Miyama T, et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) [Letter]. Int J Infect Dis. 2020;94:154-155. [PMID: 32179137] doi:10.1016/j.ijid.2020.03.020. - PMC - PubMed
    1. Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020. [PMID: 32083643] doi:10.1001/jama.2020.2565. - PMC - PubMed
    1. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients [Letter]. N Engl J Med. 2020;382:1177-1179. [PMID: 32074444] doi:10.1056/NEJMc2001737. - PMC - PubMed
    1. Kimball A, Hatfield KM, Arons M, et al; Public Health – Seattle & King County. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility β€” King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:377-381. [PMID: 32240128] doi:10.15585/mmwr.mm6913e1. - PMC - PubMed
Cite

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.